Content about Polyneuropathy

June 19, 2012
FDA declines to approve Pfizer's tafamidis meglumine

The Food and Drug Administration has declined to approve a drug designed to treat a rare, progressive and fatal neurodegenerative disease.

February 15, 2012
FDA accepts Pfizer application for genetic disease drug

The Food and Drug Administration will review a regulatory approval application from Pfizer for a drug to treat an extremely rare and fatal degenerative disease, Pfizer said Wednesday.

October 17, 2010
NeurogesX seeks expanded approval for Qutenza

A company that develops drugs for pain is hoping to get approval of one of...

© 2013 Drug Store News. All Rights Reserved.